Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

14.31

+0.36 (2.58%)

At close: Mar 16, 2026, 4:00 PM EDT

14.10

-0.21 (-1.47%)

After-hours: Mar 16, 2026, 7:50 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	283.06	235.13	175.51	134.03	45.61
Revenue Growth (YoY)	20.38%	33.97%	30.95%	193.89%	-9.01%
Cost of Revenue	32.67	28.25	14.15	5.66	1.09
Gross Profit	250.39	206.89	161.37	128.37	44.51
Selling, General & Admin	101.79	172.03	195.04	196.37	173.54
Research & Development	32.51	20.79	49.64	44.99	51.14
Other Operating Expenses	11.18	18.76	8.38	-1.52	0.57
Total Operating Expenses	145.48	211.57	253.06	239.84	225.25
Operating Income	104.91	-4.69	-91.69	-111.47	-180.74
Interest Income	13.57	16.97	17	5.12	0.53
Interest Expense	-4.33	-4.84	-2.78	-	-
Total Non-Operating Income (Expense)	9.24	12.14	14.22	5.12	0.53
Pretax Income	114.16	7.45	-77.47	-106.35	-180.21
Provision for Income Taxes	-173.05	1.7	0.55	1.83	0.76
Net Income	287.2	5.75	-78.02	-108.18	-180.97
Net Income to Common	287.2	5.75	-78.02	-108.18	-180.97
Net Income Growth	4893.08%	-	-	-	-
Shares Outstanding (Basic)	134	143	143	142	136
Shares Outstanding (Diluted)	139	146	143	142	136
Shares Change (YoY)	-5.13%	2.07%	0.93%	4.43%	9.43%
EPS (Basic)	2.14	0.04	-0.54	-0.76	-1.56
EPS (Diluted)	2.07	0.04	-0.54	-0.76	-1.56
EPS Growth	5075.00%	-	-	-	-
Free Cash Flow	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Growth	206.99%	-	-	-	-
Free Cash Flow Per Share	0.98	0.30	-0.24	-0.56	-1.16
Gross Margin	88.46%	87.99%	91.94%	95.77%	97.61%
Operating Margin	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Profit Margin	101.47%	2.45%	-44.45%	-80.71%	-396.81%
FCF Margin	47.84%	18.76%	-19.47%	-59.55%	-346.44%
EBITDA	124.36	14.76	-80.04	-108.76	-177.97
EBITDA Margin	43.94%	6.28%	-45.61%	-81.15%	-390.25%
EBIT	104.91	-4.69	-91.69	-111.47	-180.74
EBIT Margin	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Effective Tax Rate	-151.59%	22.77%	-0.71%	-1.72%	-0.42%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q